Back
Brookfield Vs. Xtacy Therapeutics Industry Stock Comparison
Buy
73
BN.TO
Brookfield
Last Price:
60.53
Seasonality Move:
2.62%
Sell
22
XTCY.CX
Xtacy Therapeutics
Last Price:
0.03
Seasonality Move:
2.91%
Buy
73
Brookfield (BN.TO)
is a Buy
Is Brookfield a Buy, Sell or Hold?
- The current Brookfield [BN.TO] share price is $60.53. The Score for BN.TO is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- BN.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.03. The Score for XTCY.CX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BN.TO Stock Price Chart
What is Brookfield's stock price today?
-
The Brookfield share price today is $60.53
The current trend is moderately bullish and BN.TO is experiencing slight buying pressure.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing selling pressure, which indicates risk of future bearish movement.
BN.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.53 | Buy |
| Relative Strength Index (14 RSI): | 68.43 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.39 - 60.09) | Buy |
| Bollinger Bands (100): | (52.9 - 57.5) | Buy |
XTCY.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 42.34 | Sell |
| Chaikin Money Flow: | -96000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.03 - 0.05) | Sell |
| Bollinger Bands (100): | (0.03 - 0.07) | Sell |
BN.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.59 | Sell |
| 20-day SMA: | 58.16 | Buy |
| 50-day SMA: | 56.48 | Buy |
| 200-day SMA: | 50.44 | Buy |
| 8-day EMA: | 60.26 | Buy |
| 20-day EMA: | 58.7 | Buy |
| 50-day EMA: | 56.85 | Buy |
| 200-day EMA: | 52.05 | Buy |
XTCY.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.04 | Sell |
| 20-day SMA: | 0.04 | Sell |
| 50-day SMA: | 0.05 | Sell |
| 200-day SMA: | 0.05 | Sell |
| 8-day EMA: | 0.04 | Sell |
| 20-day EMA: | 0.04 | Sell |
| 50-day EMA: | 0.04 | Sell |
| 200-day EMA: | 0.06 | Sell |
Brookfield Earnings Growth & BN.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.27 per share, and an increase next year of $1.05 per share.
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Brookfield Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xtacy Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||